{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,30]],"date-time":"2026-08-30T16:28:08Z","timestamp":1788107288960,"version":"build-2803163510"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T00:00:00Z","timestamp":1762992000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T00:00:00Z","timestamp":1762992000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"DOI":"10.1186\/s12967-025-07262-z","type":"journal-article","created":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T11:43:37Z","timestamp":1763034217000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Multi-omics analysis reveals the crosstalk of epigenetic regulatory networks in cutaneous squamous cell carcinoma progression"],"prefix":"10.1186","volume":"23","author":[{"given":"Ya-Zhou","family":"Sun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan-Dan","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin-Jie","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Li","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia-Hao","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia-Ying","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ke","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Tong","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xian-Xin","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuan","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tian-Shun","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,13]]},"reference":[{"key":"7262_CR1","doi-asserted-by":"crossref","unstructured":"Rogers HW, et al. Incidence estimate of nonmelanoma skin cancer in the United States, 2006. Arch Dermatol. 2010;146(3):283\u201387","DOI":"10.1001\/archdermatol.2010.19"},{"key":"7262_CR2","doi-asserted-by":"crossref","unstructured":"Ratushny V, et al. From keratinocyte to cancer: the pathogenesis and modeling of cutaneous squamous cell carcinoma. J. Clin. Invest. 2012;122(2):464\u201372","DOI":"10.1172\/JCI57415"},{"key":"7262_CR3","doi-asserted-by":"crossref","unstructured":"Nehal KS, Bichakjian CK. Update on keratinocyte carcinomas. N Engl J Med. 2018;379(4):363\u201374","DOI":"10.1056\/NEJMra1708701"},{"key":"7262_CR4","doi-asserted-by":"crossref","unstructured":"Eigentler TK, et al. Survival of patients with cutaneous squamous cell carcinoma: results of a prospective cohort study. The J Invest Dermatol. 2017;137(11):2309\u201315","DOI":"10.1016\/j.jid.2017.06.025"},{"key":"7262_CR5","doi-asserted-by":"crossref","unstructured":"Kivisaari A, K\u00e4h\u00e4ri VM. Squamous cell carcinoma of the skin: emerging need for novel biomarkers. World J Clin Oncol. 2013;4(4):85\u201390","DOI":"10.5306\/wjco.v4.i4.85"},{"key":"7262_CR6","doi-asserted-by":"crossref","unstructured":"Ko CJ. Actinic keratosis: facts and controversies. Clin Dermatol. 2010;28(3):249\u201353","DOI":"10.1016\/j.clindermatol.2009.06.009"},{"key":"7262_CR7","doi-asserted-by":"crossref","unstructured":"Chitsazzadeh V, et al. Cross-species identification of genomic drivers of squamous cell carcinoma development across preneoplastic intermediates. Nat Commun. 2016;7:12601","DOI":"10.1038\/ncomms12601"},{"key":"7262_CR8","doi-asserted-by":"crossref","unstructured":"Inman GJ, et al. The genomic landscape of cutaneous SCC reveals drivers and a novel azathioprine associated mutational signature. Nat Commun. 2018;9(1):3667","DOI":"10.1038\/s41467-018-06027-1"},{"key":"7262_CR9","doi-asserted-by":"crossref","unstructured":"Brash DE, et al. A role for sunlight in skin cancer: UV-induced p53 mutations in squamous cell carcinoma. Proc Natl Acad Sci U S A. 1991;88(22):10124\u201328","DOI":"10.1073\/pnas.88.22.10124"},{"key":"7262_CR10","doi-asserted-by":"crossref","unstructured":"Riihil\u00e4 P, et al. Complement factor I promotes progression of cutaneous squamous cell carcinoma. The J Invest Dermatol. 2015;135(2):579\u201388","DOI":"10.1038\/jid.2014.376"},{"key":"7262_CR11","doi-asserted-by":"crossref","unstructured":"Martincorena I, et al. Tumor evolution. High burden and pervasive positive selection of somatic mutations in normal human skin. Science. 2015;348(6237):880\u201386","DOI":"10.1126\/science.aaa6806"},{"key":"7262_CR12","doi-asserted-by":"crossref","unstructured":"Kashyap MP, et al. Epigenetic regulation in the pathogenesis of non-melanoma skin cancer. Semin Cancer Biol. 2022;83:36\u201356","DOI":"10.1016\/j.semcancer.2020.11.009"},{"key":"7262_CR13","doi-asserted-by":"crossref","unstructured":"Penta D, Somashekar BS, Meeran SM. Epigenetics of skin cancer: interventions by selected bioactive phytochemicals. Photodermatol Photoimmunol Photomed. 2018;34(1):42\u201349","DOI":"10.1111\/phpp.12353"},{"key":"7262_CR14","doi-asserted-by":"crossref","unstructured":"Napoli S, et al. Functional roles of matrix metalloproteinases and their inhibitors in melanoma. Cells. 2020;9(5)","DOI":"10.3390\/cells9051151"},{"key":"7262_CR15","doi-asserted-by":"crossref","unstructured":"Herv\u00e1s-Mar\u00edn D, et al. Genome wide DNA methylation profiling identifies specific epigenetic features in high-risk cutaneous squamous cell carcinoma. PLoS One. 2019;14(12):e0223341","DOI":"10.1371\/journal.pone.0223341"},{"key":"7262_CR16","doi-asserted-by":"crossref","unstructured":"Li L, et al. UVB induces cutaneous squamous cell carcinoma progression by de novo ID4 methylation via methylation regulating enzymes. EBioMedicine. 2020;57:102835","DOI":"10.1016\/j.ebiom.2020.102835"},{"key":"7262_CR17","doi-asserted-by":"crossref","unstructured":"Desrosiers R, Friderici K, Rottman F. Identification of methylated nucleosides in messenger RNA from Novikoff hepatoma cells. Proc Natl Acad Sci U S A. 1974;71(10):3971\u201375","DOI":"10.1073\/pnas.71.10.3971"},{"key":"7262_CR18","doi-asserted-by":"crossref","unstructured":"Liu L, et al. Insights into N6-methyladenosine and programmed cell death in cancer. Mol Cancer. 2022;21(1):32","DOI":"10.1186\/s12943-022-01508-w"},{"key":"7262_CR19","doi-asserted-by":"crossref","unstructured":"An Y, Duan H. The role of m6A RNA methylation in cancer metabolism. Mol Cancer. 2022;21(1):14","DOI":"10.1186\/s12943-022-01500-4"},{"key":"7262_CR20","doi-asserted-by":"crossref","unstructured":"Du F, et al. Identification of m(6)A regulator-associated methylation modification clusters and immune profiles in melanoma. Front. Cell Dev. Biol. 2021;9:761134","DOI":"10.3389\/fcell.2021.761134"},{"key":"7262_CR21","doi-asserted-by":"crossref","unstructured":"Wu XR, et al. Prognostic signature and immune efficacy of m(1) A-, m(5) C- and m(6) A-related regulators in cutaneous melanoma. J Cell Mol Med. 2021;25(17):8405\u201318","DOI":"10.1111\/jcmm.16800"},{"key":"7262_CR22","doi-asserted-by":"crossref","unstructured":"Zhou R, et al. METTL3 mediated m(6)A modification plays an oncogenic role in cutaneous squamous cell carcinoma by regulating \u0394Np63. Biochem Biophys Res Commun. 2019;515(2):310\u201317","DOI":"10.1016\/j.bbrc.2019.05.155"},{"key":"7262_CR23","doi-asserted-by":"crossref","unstructured":"Lazaroff J, et al. A prospective cohort study evaluating m(6)A RNA methylation in cutaneous squamous cell carcinoma. J Am Acad Dermatol. 2023;89(5):1083\u201384","DOI":"10.1016\/j.jaad.2023.07.1017"},{"key":"7262_CR24","doi-asserted-by":"crossref","unstructured":"Xiang Y, et al. RNA m(6)A methylation regulates the ultraviolet-induced DNA damage response. Nature. 2017;543(7646):573\u201376","DOI":"10.1038\/nature21671"},{"key":"7262_CR25","doi-asserted-by":"crossref","unstructured":"Kan RL, Chen J, Sallam T. Crosstalk between epitranscriptomic and epigenetic mechanisms in gene regulation. Trends Genet. 2022;38(2):182\u201393","DOI":"10.1016\/j.tig.2021.06.014"},{"key":"7262_CR26","doi-asserted-by":"crossref","unstructured":"Deng S, et al. RNA m(6)A regulates transcription via DNA demethylation and chromatin accessibility. Nat Genet. 2022;54(9):1427\u201337","DOI":"10.1038\/s41588-022-01173-1"},{"key":"7262_CR27","doi-asserted-by":"crossref","unstructured":"Liu XH, et al. Co-effects of m6A and chromatin accessibility dynamics in the regulation of cardiomyocyte differentiation. Epigenet Chromatin. 2023;16(1):32","DOI":"10.1186\/s13072-023-00506-6"},{"key":"7262_CR28","doi-asserted-by":"crossref","unstructured":"Zou DD, et al. Single-cell sequencing highlights heterogeneity and malignant progression in actinic keratosis and cutaneous squamous cell carcinoma. Elife. 2023;12","DOI":"10.7554\/eLife.85270"},{"key":"7262_CR29","doi-asserted-by":"crossref","unstructured":"Li S, et al. m6A topological transition coupled to developmental regulation of gene expression during mammalian tissue development. Front. Cell Dev. Biol. 2022;10:916423","DOI":"10.3389\/fcell.2022.916423"},{"issue":"8","key":"7262_CR30","doi-asserted-by":"publisher","first-page":"4105","DOI":"10.4049\/jimmunol.164.8.4105","volume":"164","author":"K Tamada","year":"2000","unstructured":"Tamada K, et al. LIGHT, a TNF-like molecule, costimulates T cell proliferation and is required for dendritic cell-mediated allogeneic T cell response. The J Immunol. 2000;164(8):4105\u201310","journal-title":"The J Immunol"},{"issue":"7209","key":"7262_CR31","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1038\/nature07185","volume":"455","author":"L Mac\u016frek","year":"2008","unstructured":"Mac\u016frek L, et al. Polo-like kinase-1 is activated by aurora a to promote checkpoint recovery. Nature. 2008;455(7209):119\u201323","journal-title":"Nature"},{"issue":"1","key":"7262_CR32","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1038\/ng1279","volume":"36","author":"H Katayama","year":"2004","unstructured":"Katayama H, et al. Phosphorylation by aurora kinase a induces Mdm2-mediated destabilization and inhibition of p53. Nat Genet. 2004;36(1):55\u201362","journal-title":"Nat Genet"},{"issue":"1","key":"7262_CR33","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1038\/s41467-018-03025-1","volume":"9","author":"M Rodr\u00edguez-Paredes","year":"2018","unstructured":"Rodr\u00edguez-Paredes M, et al. Methylation profiling identifies two subclasses of squamous cell carcinoma related to distinct cells of origin. Nat Commun. 2018;9(1):577","journal-title":"Nat Commun"},{"issue":"1","key":"7262_CR34","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1111\/exd.14183","volume":"30","author":"P Riihil\u00e4","year":"2021","unstructured":"Riihil\u00e4 P, Nissinen L, K\u00e4h\u00e4ri VM. Matrix metalloproteinases in keratinocyte carcinomas. Exp Dermatol. 2021;30(1):50\u201361","journal-title":"Exp Dermatol"},{"issue":"50","key":"7262_CR35","doi-asserted-by":"publisher","first-page":"83554","DOI":"10.18632\/oncotarget.13446","volume":"7","author":"V Farsam","year":"2016","unstructured":"Farsam V, et al. Senescent fibroblast-derived Chemerin promotes squamous cell carcinoma migration. Oncotarget. 2016;7(50):83554\u201369","journal-title":"Oncotarget"},{"key":"7262_CR36","first-page":"216","volume-title":"A decade of global mRNA and miRNA profiling of HPV-Positive cell lines and clinical specimens","author":"B Kaczkowski","year":"2012","unstructured":"Kaczkowski B, et al. A decade of global mRNA and miRNA profiling of HPV-Positive cell lines and clinical specimens. Vol. 6. Open Virol J; 2012. p. 216\u201331"},{"issue":"15","key":"7262_CR37","doi-asserted-by":"publisher","first-page":"7082","DOI":"10.1158\/0008-5472.CAN-07-1872","volume":"67","author":"R Metz","year":"2007","unstructured":"Metz R, et al. Novel tryptophan catabolic enzyme IDO2 is the preferred biochemical target of the antitumor indoleamine 2, 3-dioxygenase inhibitory compound D-1-methyl-tryptophan. Cancer Res. 2007;67(15):7082\u201387","journal-title":"Cancer Res"},{"issue":"12","key":"7262_CR38","doi-asserted-by":"publisher","first-page":"e446","DOI":"10.1111\/jdv.15763","volume":"33","author":"T Gambichler","year":"2019","unstructured":"Gambichler T, et al. Expression of indolamine-2, 3-dioxygenase and cyclooxygenase-2 in different disease stages of cutaneous squamous cell carcinoma. J Eur Acad Dermatol Venereol. 2019;33(12):e446\u201347","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"7262_CR39","doi-asserted-by":"crossref","unstructured":"Kumagai Y, Nio-Kobayashi J, Ishihara S, et al. The interferon-\u03b2\/STAT1 axis drives the collective invasion of skin squamous cell carcinoma with sealed intercellular spaces. Oncogenesis. 2022;11:27","DOI":"10.1038\/s41389-022-00403-9"},{"key":"7262_CR40","doi-asserted-by":"publisher","first-page":"102461","DOI":"10.1016\/j.ctrv.2022.102461","volume":"110","author":"Y Fujiwara","year":"2022","unstructured":"Fujiwara Y, et al. Indoleamine 2, 3-dioxygenase (IDO) inhibitors and cancer immunotherapy. Cancer Treat Rev. 2022;110:102461","journal-title":"Cancer Treat Rev"},{"key":"7262_CR41","doi-asserted-by":"crossref","unstructured":"Ziogas DC, et al. Beyond CTLA-4 and PD-1 inhibition: novel immune checkpoint molecules for melanoma treatment. Cancers (basel). 2023;15(10)","DOI":"10.3390\/cancers15102718"},{"key":"7262_CR42","doi-asserted-by":"publisher","first-page":"6348","DOI":"10.1126\/science.aal2380","volume":"357","author":"WA Flavahan","year":"2017","unstructured":"Flavahan WA, Gaskell E, Bernstein BE. Epigenetic plasticity and the hallmarks of cancer. Science. 2017;357:6348","journal-title":"Science"},{"issue":"11","key":"7262_CR43","doi-asserted-by":"publisher","first-page":"6251","DOI":"10.1093\/nar\/gkaa347","volume":"48","author":"H Zhang","year":"2020","unstructured":"Zhang H, et al. Dynamic landscape and evolution of m6A methylation in human. Nucleic Acids Res. 2020;48(11):6251\u201364","journal-title":"Nucleic Acids Res"},{"issue":"6","key":"7262_CR44","doi-asserted-by":"publisher","first-page":"1388","DOI":"10.1016\/j.cell.2015.05.014","volume":"161","author":"X Wang","year":"2015","unstructured":"Wang X, et al. N(6)-methyladenosine modulates Messenger RNA translation efficiency. Cell. 2015;161(6):1388\u201399","journal-title":"Cell"},{"issue":"7481","key":"7262_CR45","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1038\/nature12730","volume":"505","author":"X Wang","year":"2014","unstructured":"Wang X, et al. N6-methyladenosine-dependent regulation of messenger RNA stability. Nature. 2014;505(7481):117\u201320","journal-title":"Nature"},{"issue":"8","key":"7262_CR46","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1111\/exd.14153","volume":"30","author":"JPH Smits","year":"2021","unstructured":"Smits JPH, et al. Terminal keratinocyte differentiation in vitro is associated with a stable DNA methylome. Exp Dermatol. 2021;30(8):1023\u201332","journal-title":"Exp Dermatol"},{"issue":"5","key":"7262_CR47","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1002\/jcb.25392","volume":"117","author":"B Sobiak","year":"2016","unstructured":"Sobiak B, Graczyk-Jarzynka A, Le\u015bniak W. Comparison of DNA methylation and expression pattern of S100 and other epidermal differentiation complex genes in differentiating keratinocytes. J Cell Biochem. 2016;117(5):1092\u201398","journal-title":"J Cell Biochem"},{"key":"7262_CR48","doi-asserted-by":"crossref","unstructured":"Sobiak B, Le\u015bniak W. The effect of single CpG demethylation on the pattern of DNA-Protein binding. Int J Mol Sci. 2019;20(4)","DOI":"10.3390\/ijms20040914"},{"key":"7262_CR49","doi-asserted-by":"crossref","unstructured":"Zhang Y, et al. Epigenetic regulation of p63 blocks squamous-to-neuroendocrine transdifferentiation in esophageal development and malignancy. Sci Adv. 2024;10(41):eadq 0479","DOI":"10.1126\/sciadv.adq0479"},{"issue":"5","key":"7262_CR50","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1111\/j.1365-2133.2006.07487.x","volume":"155","author":"K Murao","year":"2006","unstructured":"Murao K, et al. Epigenetic abnormalities in cutaneous squamous cell carcinomas: frequent inactivation of the RB1\/p16 and p53 pathways. Br J Dermatol. 2006;155(5):999\u20131005","journal-title":"Br J Dermatol"},{"issue":"5","key":"7262_CR51","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1111\/j.0022-202X.2004.22501.x","volume":"122","author":"VL Brown","year":"2004","unstructured":"Brown VL, et al. p16INK4a and p14ARF tumor suppressor genes are commonly inactivated in cutaneous squamous cell carcinoma. The J Invest Dermatol. 2004;122(5):1284\u201392","journal-title":"The J Invest Dermatol"},{"issue":"10","key":"7262_CR52","doi-asserted-by":"publisher","first-page":"e0187047","DOI":"10.1371\/journal.pone.0187047","volume":"12","author":"Y Nobeyama","year":"2017","unstructured":"Nobeyama Y, Watanabe Y, Nakagawa H. Silencing of G0\/G1 switch gene 2 in cutaneous squamous cell carcinoma. PLoS One. 2017;12(10):e0187047","journal-title":"PLoS One"},{"issue":"33","key":"7262_CR53","doi-asserted-by":"publisher","first-page":"13710","DOI":"10.1073\/pnas.1110931108","volume":"108","author":"E Botti","year":"2011","unstructured":"Botti E, et al. Developmental factor IRF6 exhibits tumor suppressor activity in squamous cell carcinomas. Proc Natl Acad Sci U S A. 2011;108(33):13710\u201315","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"8","key":"7262_CR54","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1097\/01.LAB.0000025391.35798.F1","volume":"82","author":"T Takeuchi","year":"2002","unstructured":"Takeuchi T, et al. Loss of T-cadherin (CDH13, H-cadherin) expression in cutaneous squamous cell carcinoma. Lab Invest. 2002;82(8):1023\u201329","journal-title":"Lab Invest"},{"issue":"6163","key":"7262_CR55","doi-asserted-by":"publisher","first-page":"1226","DOI":"10.1126\/science.1239730","volume":"342","author":"X Lim","year":"2013","unstructured":"Lim X, et al. Interfollicular epidermal stem cells self-renew via autocrine wnt signaling. Science. 2013;342(6163):1226\u201330","journal-title":"Science"},{"issue":"9","key":"7262_CR56","doi-asserted-by":"publisher","first-page":"e11073","DOI":"10.15252\/msb.202211073","volume":"18","author":"L Sol\u00e9-Boldo","year":"2022","unstructured":"Sol\u00e9-Boldo L, et al. Differentiation-related epigenomic changes define clinically distinct keratinocyte cancer subclasses. Mol Syst Biol. 2022;18(9):e11073","journal-title":"Mol Syst Biol"},{"key":"7262_CR57","doi-asserted-by":"crossref","unstructured":"Martin MT, Vulin A, Hendry JH. Human epidermal stem cells: role in adverse skin reactions and carcinogenesis from radiation. Mutat Res Rev Mutat Res. 2016;770(Pt B):349\u201368","DOI":"10.1016\/j.mrrev.2016.08.004"},{"key":"7262_CR58","unstructured":"Morris RJ, et al. Evidence that cutaneous carcinogen-initiated epithelial cells from mice are quiescent rather than actively cycling. Cancer Res. 1997;57(16):3436\u201343"},{"key":"7262_CR59","doi-asserted-by":"crossref","unstructured":"Sun T, et al. Crosstalk between RNA m(6)A and DNA methylation regulates transposable element chromatin activation and cell fate in human pluripotent stem cells. Nat Genet. 2023;55(8):1324\u201335","DOI":"10.1038\/s41588-023-01452-5"}],"updated-by":[{"DOI":"10.1186\/s12967-026-07833-8","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T00:00:00Z","timestamp":1770940800000}}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-025-07262-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-025-07262-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-025-07262-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,14]],"date-time":"2026-02-14T06:41:15Z","timestamp":1771051275000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12967-025-07262-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,13]]},"references-count":59,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["7262"],"URL":"https:\/\/doi.org\/10.1186\/s12967-025-07262-z","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,13]]},"assertion":[{"value":"15 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 February 2026","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Article updated for adding revised Figure 9.","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 February 2026","order":8,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":9,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":10,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1186\/s12967-026-07833-8","URL":"https:\/\/doi.org\/10.1186\/s12967-026-07833-8","order":11,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors are accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved. All procedures performed in this study involving human participants were in accordance with the Declaration of Helsinki (as revised in 2013). This study protocol was approved by the Ethics Committee of the First Affiliated Hospital of Kunming Medical University (Approval Number (2020)-L-29), and written informed consent was obtained from all patients.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"The authors have no conflicts of interest to declare.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}],"article-number":"1281"}}